Cargando…

Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study

BACKGROUND: The indications for continuous oral anticoagulant treatment, the target interval and the procedures for withdrawing treatment have changed in the last 10 years. METHODS: Patients on continuous oral anticoagulant treatment at the Outpatient Anticoagulant Clinic at Umeå University Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekblom, Kim, Hultdin, Johan, Carlberg, Bo, Strand, Tage
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325044/
https://www.ncbi.nlm.nih.gov/pubmed/16336670
http://dx.doi.org/10.1186/1477-9560-3-20
_version_ 1782126465145372672
author Ekblom, Kim
Hultdin, Johan
Carlberg, Bo
Strand, Tage
author_facet Ekblom, Kim
Hultdin, Johan
Carlberg, Bo
Strand, Tage
author_sort Ekblom, Kim
collection PubMed
description BACKGROUND: The indications for continuous oral anticoagulant treatment, the target interval and the procedures for withdrawing treatment have changed in the last 10 years. METHODS: Patients on continuous oral anticoagulant treatment at the Outpatient Anticoagulant Clinic at Umeå University Hospital in 2002 were included in a descriptive study (n = 900). 263 of those had a mechanical heart valve prosthesis. Only patient records for patients with other indications than mechanical heart valve prosthesis were examined. 582 of those records were found. In the 55 remaining patients some clinical information was retrieved from the computerised warfarin dosage database. These latter, more unsure clinical data, are presented separately. Anticoagulant treatment was discontinued if lack of proper indication or presence of too high risk for hemorrhagic complications were found. RESULTS: The prevalence of continuous oral anticoagulant treatment in the uptake area was 0.65%. The most common target interval was INR 2.1–3.0, but patients with a mechanical heart valve prosthesis were often treated more aggressively, i.e. with a higher INR target interval. Of the patients on continuous treatment, 26.6% of the INR values were outside 2.0–3.0. The most common reasons for oral anticoagulant treatment were atrial fibrillation or mechanical heart valve prosthesis, in contrast to earlier findings in studies of our population in 1987 and 1990. We found 90 patients (10.0%) without proper indication for oral anticoagulant treatment or too high risk, and their treatment was discontinued. CONCLUSION: In patients on oral anticoagulant therapy, re-evaluation of indications and risks resulted in a substantial number of treatment withdrawals. There have been major changes in treatment indications during the last decade, possibly due to rapid development of knowledge in the field of thrombosis risk factors. Treatment should be re-considered once a year.
format Text
id pubmed-1325044
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13250442006-01-05 Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study Ekblom, Kim Hultdin, Johan Carlberg, Bo Strand, Tage Thromb J Original Clinical Investigation BACKGROUND: The indications for continuous oral anticoagulant treatment, the target interval and the procedures for withdrawing treatment have changed in the last 10 years. METHODS: Patients on continuous oral anticoagulant treatment at the Outpatient Anticoagulant Clinic at Umeå University Hospital in 2002 were included in a descriptive study (n = 900). 263 of those had a mechanical heart valve prosthesis. Only patient records for patients with other indications than mechanical heart valve prosthesis were examined. 582 of those records were found. In the 55 remaining patients some clinical information was retrieved from the computerised warfarin dosage database. These latter, more unsure clinical data, are presented separately. Anticoagulant treatment was discontinued if lack of proper indication or presence of too high risk for hemorrhagic complications were found. RESULTS: The prevalence of continuous oral anticoagulant treatment in the uptake area was 0.65%. The most common target interval was INR 2.1–3.0, but patients with a mechanical heart valve prosthesis were often treated more aggressively, i.e. with a higher INR target interval. Of the patients on continuous treatment, 26.6% of the INR values were outside 2.0–3.0. The most common reasons for oral anticoagulant treatment were atrial fibrillation or mechanical heart valve prosthesis, in contrast to earlier findings in studies of our population in 1987 and 1990. We found 90 patients (10.0%) without proper indication for oral anticoagulant treatment or too high risk, and their treatment was discontinued. CONCLUSION: In patients on oral anticoagulant therapy, re-evaluation of indications and risks resulted in a substantial number of treatment withdrawals. There have been major changes in treatment indications during the last decade, possibly due to rapid development of knowledge in the field of thrombosis risk factors. Treatment should be re-considered once a year. BioMed Central 2005-12-08 /pmc/articles/PMC1325044/ /pubmed/16336670 http://dx.doi.org/10.1186/1477-9560-3-20 Text en Copyright © 2005 Ekblom et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Clinical Investigation
Ekblom, Kim
Hultdin, Johan
Carlberg, Bo
Strand, Tage
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title_full Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title_fullStr Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title_full_unstemmed Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title_short Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
title_sort anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
topic Original Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325044/
https://www.ncbi.nlm.nih.gov/pubmed/16336670
http://dx.doi.org/10.1186/1477-9560-3-20
work_keys_str_mv AT ekblomkim anticoagulanttreatmentataspecializedoutpatientanticoagulanttherapyunitadescriptivestudy
AT hultdinjohan anticoagulanttreatmentataspecializedoutpatientanticoagulanttherapyunitadescriptivestudy
AT carlbergbo anticoagulanttreatmentataspecializedoutpatientanticoagulanttherapyunitadescriptivestudy
AT strandtage anticoagulanttreatmentataspecializedoutpatientanticoagulanttherapyunitadescriptivestudy